Stenotrophomonas maltophilia: Complicating treatment of ESBL UTI
Stenotrophomonas maltophilia (S. maltophilia) is a gram-negative bacillus emerging as an opportunistic, nosocomial pathogen associated with a high mortality rate. The organism has been shown to survive several biocides used in the hospital setting. Hospital water sources can serve as a reservoir for...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Advanced Biomedical Research |
Subjects: | |
Online Access: | http://www.advbiores.net/article.asp?issn=2277-9175;year=2015;volume=4;issue=1;spage=36;epage=36;aulast=Kumar |
id |
doaj-8aa79416109b48fcbc822dff89a02169 |
---|---|
record_format |
Article |
spelling |
doaj-8aa79416109b48fcbc822dff89a021692020-11-24T23:55:30ZengWolters Kluwer Medknow PublicationsAdvanced Biomedical Research2277-91752277-91752015-01-0141363610.4103/2277-9175.151241Stenotrophomonas maltophilia: Complicating treatment of ESBL UTISimit KumarMaitreyi BandyopadhyayMitali ChatterjeeParthajit BanerjeeSumon PoddarDebarati BanerjeeStenotrophomonas maltophilia (S. maltophilia) is a gram-negative bacillus emerging as an opportunistic, nosocomial pathogen associated with a high mortality rate. The organism has been shown to survive several biocides used in the hospital setting. Hospital water sources can serve as a reservoir for S. maltophilia. The transmission of S. maltophilia to susceptible individuals may occur through direct contact with the source or through the hands of health care personnel. S. maltophilia is usually resistant to third-generation cephalosporins, aminoglycosides and antipseudomonal penicillins. These microorganisms are intrinsically resistant to carbapenems, and exposure to these agents has been linked to selection of S. maltophilia. There have also been reports of the organism developing resistance to trimethoprim-sulfamethoxazole (TMP-SMX), which was initially considered as the drug of choice for S. maltophillia infections. We describe a case of nosocomial urinary tract infection (UTI) due to S. maltophilia in a diabetic patient, which the patient developed during treatment with meropenem for UTI due to Klebsiella pneumonia that was resistant to TMP-SMX.http://www.advbiores.net/article.asp?issn=2277-9175;year=2015;volume=4;issue=1;spage=36;epage=36;aulast=KumarAntimicrobial sensitivityStenotrophomonas maltophiliaurinary tract infection |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Simit Kumar Maitreyi Bandyopadhyay Mitali Chatterjee Parthajit Banerjee Sumon Poddar Debarati Banerjee |
spellingShingle |
Simit Kumar Maitreyi Bandyopadhyay Mitali Chatterjee Parthajit Banerjee Sumon Poddar Debarati Banerjee Stenotrophomonas maltophilia: Complicating treatment of ESBL UTI Advanced Biomedical Research Antimicrobial sensitivity Stenotrophomonas maltophilia urinary tract infection |
author_facet |
Simit Kumar Maitreyi Bandyopadhyay Mitali Chatterjee Parthajit Banerjee Sumon Poddar Debarati Banerjee |
author_sort |
Simit Kumar |
title |
Stenotrophomonas maltophilia: Complicating treatment of ESBL UTI |
title_short |
Stenotrophomonas maltophilia: Complicating treatment of ESBL UTI |
title_full |
Stenotrophomonas maltophilia: Complicating treatment of ESBL UTI |
title_fullStr |
Stenotrophomonas maltophilia: Complicating treatment of ESBL UTI |
title_full_unstemmed |
Stenotrophomonas maltophilia: Complicating treatment of ESBL UTI |
title_sort |
stenotrophomonas maltophilia: complicating treatment of esbl uti |
publisher |
Wolters Kluwer Medknow Publications |
series |
Advanced Biomedical Research |
issn |
2277-9175 2277-9175 |
publishDate |
2015-01-01 |
description |
Stenotrophomonas maltophilia (S. maltophilia) is a gram-negative bacillus emerging as an opportunistic, nosocomial pathogen associated with a high mortality rate. The organism has been shown to survive several biocides used in the hospital setting. Hospital water sources can serve as a reservoir for S. maltophilia. The transmission of S. maltophilia to susceptible individuals may occur through direct contact with the source or through the hands of health care personnel. S. maltophilia is usually resistant to third-generation cephalosporins, aminoglycosides and antipseudomonal penicillins. These microorganisms are intrinsically resistant to carbapenems, and exposure to these agents has been linked to selection of S. maltophilia. There have also been reports of the organism developing resistance to trimethoprim-sulfamethoxazole (TMP-SMX), which was initially considered as the drug of choice for S. maltophillia infections. We describe a case of nosocomial urinary tract infection (UTI) due to S. maltophilia in a diabetic patient, which the patient developed during treatment with meropenem for UTI due to Klebsiella pneumonia that was resistant to TMP-SMX. |
topic |
Antimicrobial sensitivity Stenotrophomonas maltophilia urinary tract infection |
url |
http://www.advbiores.net/article.asp?issn=2277-9175;year=2015;volume=4;issue=1;spage=36;epage=36;aulast=Kumar |
work_keys_str_mv |
AT simitkumar stenotrophomonasmaltophiliacomplicatingtreatmentofesbluti AT maitreyibandyopadhyay stenotrophomonasmaltophiliacomplicatingtreatmentofesbluti AT mitalichatterjee stenotrophomonasmaltophiliacomplicatingtreatmentofesbluti AT parthajitbanerjee stenotrophomonasmaltophiliacomplicatingtreatmentofesbluti AT sumonpoddar stenotrophomonasmaltophiliacomplicatingtreatmentofesbluti AT debaratibanerjee stenotrophomonasmaltophiliacomplicatingtreatmentofesbluti |
_version_ |
1725462249162670080 |